131 related articles for article (PubMed ID: 33889295)
1. Drug exposure: still relevant after all these years.
Gerber DE; Putnam WC
Oncotarget; 2021 Apr; 12(8):721-722. PubMed ID: 33889295
[No Abstract] [Full Text] [Related]
2. Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials.
Kearns GL; Artman M
Curr Pharm Des; 2015; 21(39):5636-42. PubMed ID: 26323416
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats.
Xiao M; Qian C; Luo X; Yang M; Zhang Y; Wu C; Mok C; Lee P; Zuo Z
J Ethnopharmacol; 2019 May; 235():100-110. PubMed ID: 30710735
[TBL] [Abstract][Full Text] [Related]
4. Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics.
Franconi F; Campesi I
Curr Med Chem; 2017; 24(24):2561-2575. PubMed ID: 27697075
[TBL] [Abstract][Full Text] [Related]
5. Principles and applications of pharmacometrics in drug evaluation in children.
Leroux S; Elie V; Zhao W; Magreault S; Jacqz-Aigrain E
Therapie; 2018 Apr; 73(2):165-170. PubMed ID: 29605146
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in pharmacokinetics and pharmacodynamics.
Beierle I; Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
[TBL] [Abstract][Full Text] [Related]
7. Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.
Kashuba AD; Nafziger AN
Clin Pharmacokinet; 1998 Mar; 34(3):203-18. PubMed ID: 9533982
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and pharmacokinetics of psycholeptic drugs in the course of radiation disease. The effect of premedication with cystamine on pharmacodynamics and Pharmacokinetics of nitrazepam.
Szczawińska K; Cenajek D; Chodera A; Wójciak Z; Okulicz-Kozaryn
Acta Physiol Pol; 1977; 28(2):161-8. PubMed ID: 868534
[TBL] [Abstract][Full Text] [Related]
9. Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A.
Rafehi M; Faltraco F; Matthaei J; Prukop T; Jensen O; Grytzmann A; Blome FG; Berger RG; Krings U; Vormfelde SV; Tzvetkov MV; Brockmöller J
Front Pharmacol; 2019; 10():1297. PubMed ID: 31736764
[TBL] [Abstract][Full Text] [Related]
10. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
Chen ML
Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
[TBL] [Abstract][Full Text] [Related]
11. The correlation between pharmacodynamics and pharmacokinetics: basics of pharmacokinetics--pharmacodynamics modeling.
Cawello W; Antonucci T
J Clin Pharmacol; 1997 Jan; 37(S1):65S-69S. PubMed ID: 9048287
[TBL] [Abstract][Full Text] [Related]
12. A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients.
van Erp NP; van Herpen CM; de Wit D; Willemsen A; Burger DM; Huitema AD; Kapiteijn E; Ter Heine R
Clin Pharmacokinet; 2016 Nov; 55(11):1447-1456. PubMed ID: 27299325
[TBL] [Abstract][Full Text] [Related]
13. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.
Anderson GD
J Womens Health (Larchmt); 2005; 14(1):19-29. PubMed ID: 15692274
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the Pharmacodynamics and Pharmacokinetics of MSCs to Overcome Limitations in Their Clinical Translation.
Salvadori M; Cesari N; Murgia A; Puccini P; Riccardi B; Dominici M
Mol Ther Methods Clin Dev; 2019 Sep; 14():1-15. PubMed ID: 31236426
[TBL] [Abstract][Full Text] [Related]
15. Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.
Schorzman AN; Lucas AT; Kagel JR; Zamboni WC
Methods Mol Biol; 2018; 1831():201-228. PubMed ID: 30051434
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer.
Herben VM; ten Bokkel Huinink WW; Schot ME; Hudson I; Beijnen JH
Anticancer Drugs; 1998 Jun; 9(5):411-8. PubMed ID: 9660538
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Pharmacodynamics Estimation of Eculizumab in a 2-Year-Old Girl With Atypical Hemolytic Uremic Syndrome: A Case Report With 4-Year Follow-Up.
Saida K; Fukuda T; Mizuno K; Ogura M; Kamei K; Ito S
Front Pediatr; 2019; 7():519. PubMed ID: 31921730
[No Abstract] [Full Text] [Related]
18. Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study.
Parasrampuria DA; de Boer P; Desai-Krieger D; Chow AT; Jones CR
J Clin Pharmacol; 2003 Apr; 43(4):406-13. PubMed ID: 12723461
[TBL] [Abstract][Full Text] [Related]
19. Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study.
McNamara JJ; McColley SA; Marigowda G; Liu F; Tian S; Owen CA; Stiles D; Li C; Waltz D; Wang LT; Sawicki GS
Lancet Respir Med; 2019 Apr; 7(4):325-335. PubMed ID: 30686767
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor.
Deng R; Bumbaca D; Pastuskovas CV; Boswell CA; West D; Cowan KJ; Chiu H; McBride J; Johnson C; Xin Y; Koeppen H; Leabman M; Iyer S
MAbs; 2016; 8(3):593-603. PubMed ID: 26918260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
